Enrolling by invitationNCT02327845
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Miami
- Principal Investigator
- Michael Benatar, DPhilUniversity of Miami
- Enrollment
- 700 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2026
Study locations (15)
- Stanford University, Palo Alto, California, United States
- University of California San Diego (UCSD), San Diego, California, United States
- California Pacific Medical Center (CPMC), San Francisco, California, United States
- University of Miami, Miami, Florida, United States
- University of Iowa, Iowa City, Iowa, United States
- Kansas University Medical Center (KUMC), Kansas City, Kansas, United States
- Twin Cities ALS Research Consortium, Minneapolis, Minnesota, United States
- Wake Forest University, Winston-Salem, North Carolina, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Texas Southwestern (UTSW), Dallas, Texas, United States
- University of Texas Health Science Center San Antonio (UTHSCSA), San Antonio, Texas, United States
- University of Virginia (UVA), Charlottesville, Virginia, United States
- Eberhard Karls University of Tübingen, Tübingen, Germany
- University of Cape Town, Cape Town, South Africa
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS) · National Center for Advancing Translational Sciences (NCATS) · St. Jude Children's Research Hospital · ALS Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02327845 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)